Wei Zheng Reports 6.2% Stake in Connect Biopharma Holdings Ltd (CNTB)

Wei Zheng has filed an amended Schedule 13G/A for Connect Biopharma Holdings Ltd (CNTB), reporting a beneficial ownership of 3,876,036 ordinary shares. This represents a 6.2% stake in the company based on approximately 62.6 million shares outstanding, which includes 56,521,282 shares reported in the issuer's 10-K and an additional 6,130,000 shares issued in a recent offering. The filing, dated May 15, 2026, reflects the reporting person's position as of March 31, 2026. Wei Zheng holds sole voting and dispositive power over all reported shares. This filing marks an increase from the previously reported 0.0% ownership, indicating a significant new or restored position in the clinical-stage biopharmaceutical company. The reporting person is a U.S. citizen based in Del Mar, California. The amendment is the fifth such filing for this individual regarding the issuer's securities, filed under Rule 13d-1(d).